All lobbying filings
EAST END GROUP, LLC
Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Income
$45,000.00
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
2
-
KELLY CHILDRESS LANGEPreviously held: Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser.
-
ANDREW HAWKINSPreviously held: Rep. Rogers, LA, Chief of Staff.
Government bodies contacted
6
Lobbying activity
3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Section 232 investigation into pharmaceuticals and unfair trade practices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.